Mexico Syndromic Multiplex Diagnostics Market Size & Outlook
Related Markets
Mexico syndromic multiplex diagnostics market highlights
- The Mexico syndromic multiplex diagnostics market generated a revenue of USD 85.9 million in 2024 and is expected to reach USD 104.9 million by 2030.
- The Mexico market is expected to grow at a CAGR of 3.5% from 2025 to 2030.
- In terms of segment, respiratory was the largest revenue generating type in 2024.
- Gastrointestinal is the most lucrative type segment registering the fastest growth during the forecast period.
Syndromic multiplex diagnostics market data book summary
| Market revenue in 2024 | USD 85.9 million |
| Market revenue in 2030 | USD 104.9 million |
| Growth rate | 3.5% (CAGR from 2025 to 2030) |
| Largest segment | Respiratory |
| Fastest growing segment | Gastrointestinal |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Respiratory, Gastrointestinal, Central Nervous System, Other Types of Syndromes (cUTI and STDs) |
Other key industry trends
- In terms of revenue, Mexico accounted for 1.9% of the global syndromic multiplex diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. syndromic multiplex diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 267.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Syndromic Multiplex Diagnostics Market Scope
Syndromic Multiplex Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Curetis | View profile | 101-250 | Holzgerlingen, Baden-Wurttemberg, Germany, Europe | http://www.curetis.com |
| Applied BioCode | View profile | 11-50 | Santa Fe Springs, California, United States, North America | http://apbiocode.com |
| Luminex Corp. | View profile | - | - | - |
| Becton, Dickinson & Company | View profile | - | - | - |
| QIAGEN | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Mexico syndromic multiplex diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to syndromic multiplex diagnostics market will help companies and investors design strategic landscapes.
Respiratory was the largest segment with a revenue share of 33.53% in 2024. Horizon Databook has segmented the Mexico syndromic multiplex diagnostics market based on respiratory, gastrointestinal, central nervous system, other types of syndromes (cuti and stds) covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Mexico syndromic multiplex diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico syndromic multiplex diagnostics market databook
-
Our clientele includes a mix of syndromic multiplex diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico syndromic multiplex diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Mexico syndromic multiplex diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico Type - Syndromic Multiplex Diagnostics Market size, 2024 - 2030 (US$M)
Mexico Syndromic Multiplex Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
